Patients undergoing evaluation for solid organ transplantation (SOT) often have a history of
malignancy. Although the cancer has been treated in these patients, the benefits of …

Renal cancer represents 2% to 3% of all cancers, and its incidence is rising. The increased
use of ultrasonography and cross-sectional imaging has resulted in the clinical dilemma of …

PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …

Background Long-term data comparing partial nephrectomy (PN) and thermal ablation are
lacking. Objective To update our experience with PN, percutaneous radiofrequency ablation …

Background Most reports of active surveillance (AS) of small renal masses (SRMs) lack
biopsy confirmation, and therefore include benign tumors and different subtypes of renal cell …

Abstract Background Long non-coding RNAs (lncRNAs) can be used as prognostic
biomarkers in many types of cancer. Objective We sought to establish an lncRNA signature …

Background Active surveillance (AS) has gained acceptance as a management strategy for
localized renal masses. Objective To review our large single-center experience with AS …

Cancer is an important outcome after kidney transplantation because it is the second
leading cause of death in most Western countries. The excess risk of cancer after …

Purpose To evaluate the long-term efficacy of image-guided cryoablation of sporadic clinical
T1 (cT1) biopsy-proven renal cell carcinoma (RCC) and the technical success and safety of …

As our understanding has expanded that relatively large fraction of incidentally discovered
renal masses, especially in small size, are benign or indolent even if malignant, there is …